semaglutide for pets Pet Safety Alert: Rising GLP-1 Pet Exposures semaglutide cats A biopharmaceutical company

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation

Find out which ones you should avoid.

It has been approved as a second line treatment option for better glycaemic control in type 2 diabetes and currently under scrutiny for anti-obesity purpose

Food company chief executive officers are charged with being prepared and developing strategies for potentially disruptive trends.

Learn about the 7-day schedule, the 5-day half-life, and how to safely manage end-of-week hunger.

Health Canada has approved the first generic version of Novo Nordisks diabetes drug Ozempic in Canada, with Dr Reddys Laboratories set to market the copycat treatment